Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
TransUnion a un objectif de cours consensus de $98.2, basé sur les évaluations des 24 analystes. Le plus élevé est de $130 attribué par Baird le octobre 24, 2024, et le plus bas est de $64.5 attribué par Exane BNP Paribas le janvier 6, 2023. Les 3 dernières évaluations d'analystes ont été publiées par UBS, BMO Capital et Wells Fargo le juillet 25, 2025. Avec un objectif de cours moyen de $113.67 entre UBS, BMO Capital et Wells Fargo, il y a une variation implicite de 29.70% upside pour TransUnion à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
BMO Capital
Wells Fargo
Oppenheimer
Stifel
1calculé à partir des notes des analystes
Notes d'analystes pour TransUnion
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/25/2025 | 19.81% | UBS | $98 → $105 | Maintains | Neutral | |||
07/25/2025 | 34.64% | BMO Capital | $115 → $118 | Maintains | Outperform | |||
07/25/2025 | 34.64% | Wells Fargo | $124 → $118 | Maintains | Overweight | |||
07/25/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
07/10/2025 | 31.22% | BMO Capital | → $115 | Initiates | → Outperform | |||
07/08/2025 | 23.23% | Oppenheimer | $100 → $108 | Maintains | Outperform | |||
05/22/2025 | 14.1% | Oppenheimer | $96 → $100 | Maintains | Outperform | |||
04/25/2025 | 27.8% | Stifel | $120 → $112 | Maintains | Buy | |||
04/25/2025 | 9.54% | Oppenheimer | $93 → $96 | Maintains | Outperform | |||
04/14/2025 | 33.5% | Wells Fargo | $130 → $117 | Maintains | Overweight | |||
04/04/2025 | -3.01% | Barclays | $105 → $85 | Maintains | Equal-Weight | |||
02/14/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
02/03/2025 | 18.67% | UBS | $102 → $104 | Maintains | Neutral | |||
01/28/2025 | 44.91% | Morgan Stanley | $130 → $127 | Maintains | Overweight | |||
01/16/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/15/2025 | 31.22% | Jefferies | $125 → $115 | Maintains | Buy | |||
01/10/2025 | 43.77% | Wells Fargo | $135 → $126 | Maintains | Overweight | |||
01/07/2025 | 27.8% | Oppenheimer | $115 → $112 | Maintains | Outperform | |||
12/12/2024 | 48.33% | Morgan Stanley | $119 → $130 | Maintains | Overweight | |||
11/20/2024 | 31.22% | Oppenheimer | $122 → $115 | Maintains | Outperform | |||
10/24/2024 | 38.06% | RBC Capital | $121 → $121 | Reiterates | Outperform → Outperform | |||
10/24/2024 | 35.78% | Morgan Stanley | $103 → $119 | Maintains | Overweight | |||
10/24/2024 | 36.92% | Stifel | $103 → $120 | Maintains | Buy | |||
10/24/2024 | 39.21% | Oppenheimer | $118 → $122 | Maintains | Outperform | |||
10/24/2024 | 54.04% | Wells Fargo | $125 → $135 | Maintains | Overweight | |||
10/24/2024 | 48.33% | Baird | $104 → $130 | Maintains | Outperform | |||
10/24/2024 | — | Needham | — | Reiterates | → Hold | |||
10/10/2024 | 48.33% | Wolfe Research | → $130 | Upgrade | Peer Perform → Outperform | |||
10/08/2024 | 34.64% | Oppenheimer | $97 → $118 | Maintains | Outperform | |||
10/02/2024 | 24.37% | Goldman Sachs | $97 → $109 | Maintains | Neutral | |||
10/02/2024 | 42.63% | Wells Fargo | $100 → $125 | Maintains | Overweight | |||
10/01/2024 | 25.51% | UBS | → $110 | Initiates | → Neutral | |||
09/13/2024 | 19.81% | Barclays | $80 → $105 | Maintains | Equal-Weight | |||
09/12/2024 | 17.53% | Morgan Stanley | $96 → $103 | Maintains | Overweight | |||
08/20/2024 | 10.68% | Goldman Sachs | $87 → $97 | Maintains | Neutral | |||
08/12/2024 | 14.1% | Wells Fargo | → $100 | Initiates | → Overweight | |||
07/26/2024 | 10.68% | Oppenheimer | $90 → $97 | Maintains | Outperform | |||
07/26/2024 | -8.72% | Barclays | $75 → $80 | Maintains | Equal-Weight | |||
07/26/2024 | 20.95% | RBC Capital | $85 → $106 | Maintains | Outperform | |||
07/26/2024 | 18.67% | Baird | $94 → $104 | Maintains | Outperform | |||
07/26/2024 | 4.97% | Needham | $89 → $92 | Maintains | Buy | |||
07/09/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
06/20/2024 | 4.97% | B of A Securities | → $92 | Upgrade | Neutral → Buy | |||
04/26/2024 | 2.69% | Morgan Stanley | $87 → $90 | Maintains | Overweight | |||
04/26/2024 | 4.97% | Stifel | $83 → $92 | Maintains | Buy | |||
04/26/2024 | 7.26% | Baird | $87 → $94 | Maintains | Outperform | |||
04/25/2024 | 1.55% | Needham | $87 → $89 | Maintains | Buy | |||
04/09/2024 | 2.69% | Oppenheimer | $81 → $90 | Maintains | Outperform | |||
04/01/2024 | 2.69% | B of A Securities | $65 → $90 | Upgrade | Underperform → Neutral | |||
03/26/2024 | -8.72% | Evercore ISI Group | $70 → $80 | Maintains | In-Line | |||
02/14/2024 | -3.01% | RBC Capital | $85 → $85 | Reiterates | Outperform → Outperform | |||
02/14/2024 | -3.01% | Wells Fargo | $80 → $85 | Maintains | Overweight | |||
02/14/2024 | -0.73% | Baird | $80 → $87 | Maintains | Outperform | |||
02/14/2024 | -4.15% | JP Morgan | $69 → $84 | Maintains | Overweight | |||
02/14/2024 | -14.42% | Barclays | $55 → $75 | Maintains | Equal-Weight | |||
02/14/2024 | -5.29% | Stifel | $76 → $83 | Maintains | Buy | |||
02/14/2024 | -14.42% | Truist Securities | $65 → $75 | Maintains | Hold | |||
02/13/2024 | -0.73% | Needham | $75 → $87 | Maintains | Buy | |||
01/17/2024 | -3.01% | Jefferies | $75 → $85 | Maintains | Buy | |||
12/29/2023 | -17.85% | Goldman Sachs | $63 → $72 | Maintains | Neutral | |||
12/19/2023 | -7.58% | Oppenheimer | → $81 | Initiates | → Outperform | |||
11/22/2023 | -13.28% | Morgan Stanley | $70 → $76 | Maintains | Overweight | |||
11/16/2023 | -22.41% | Deutsche Bank | $57 → $68 | Maintains | Buy | |||
11/16/2023 | -26.97% | Stifel | $59 → $64 | Maintains | Buy | |||
10/31/2023 | -28.12% | Goldman Sachs | $73 → $63 | Maintains | Neutral | |||
10/30/2023 | -28.12% | Goldman Sachs | $73 → $63 | Maintains | Neutral | |||
10/26/2023 | -32.68% | Stifel | $90 → $59 | Maintains | Buy | |||
10/26/2023 | -16.7% | Goldman Sachs | $85 → $73 | Maintains | Neutral | |||
10/25/2023 | -20.13% | RBC Capital | $97 → $70 | Maintains | Outperform | |||
10/25/2023 | -37.24% | Barclays | $80 → $55 | Maintains | Equal-Weight | |||
10/25/2023 | -16.7% | Goldman Sachs | $85 → $73 | Maintains | Neutral | |||
10/25/2023 | -20.13% | Morgan Stanley | $93 → $70 | Maintains | Overweight | |||
10/25/2023 | — | Evercore ISI Group | — | Downgrade | Outperform → In-Line | |||
10/25/2023 | -49.79% | B of A Securities | $95 → $44 | Downgrade | Buy → Underperform | |||
10/24/2023 | -14.42% | Needham | $92 → $75 | Maintains | Buy | |||
10/17/2023 | -14.42% | Truist Securities | $85 → $75 | Maintains | Hold | |||
10/02/2023 | 10.68% | RBC Capital | → $97 | Reiterates | Outperform → Outperform | |||
07/26/2023 | 6.12% | Morgan Stanley | $78 → $93 | Maintains | Overweight | |||
07/26/2023 | 10.68% | RBC Capital | $84 → $97 | Maintains | Outperform | |||
07/26/2023 | 7.26% | Wells Fargo | $88 → $94 | Maintains | Overweight | |||
07/26/2023 | -8.72% | Barclays | $67 → $80 | Maintains | Equal-Weight | |||
07/25/2023 | 4.97% | Needham | $84 → $92 | Maintains | Buy | |||
07/19/2023 | -3.01% | Truist Securities | $70 → $85 | Maintains | Hold | |||
06/05/2023 | -8.72% | Goldman Sachs | $71 → $80 | Maintains | Neutral | |||
05/18/2023 | -4.15% | RBC Capital | → $84 | Reiterates | Outperform → Outperform | |||
04/26/2023 | -20.13% | Truist Securities | $66 → $70 | Maintains | Hold | |||
04/26/2023 | -4.15% | Needham | → $84 | Upgrade | Hold → Buy | |||
03/31/2023 | -23.55% | Barclays | $72 → $67 | Maintains | Equal-Weight | |||
03/22/2023 | -11% | Morgan Stanley | $80 → $78 | Maintains | Overweight | |||
03/01/2023 | -8.72% | Exane BNP Paribas | → $80 | Upgrade | Neutral → Outperform | |||
02/15/2023 | -4.15% | B of A Securities | $91 → $84 | Maintains | Buy | |||
02/15/2023 | -5.29% | Baird | $78 → $83 | Maintains | Outperform | |||
02/15/2023 | -20.13% | Credit Suisse | $65 → $70 | Maintains | Neutral | |||
02/15/2023 | -17.85% | Barclays | $65 → $72 | Maintains | Equal-Weight | |||
02/06/2023 | -13.28% | Goldman Sachs | $67 → $76 | Maintains | Neutral | |||
02/06/2023 | -15.56% | Truist Securities | $62 → $74 | Maintains | Hold | |||
02/01/2023 | 3.83% | B of A Securities | $72 → $91 | Upgrade | Neutral → Buy | |||
01/13/2023 | 0.41% | Wells Fargo | → $88 | Upgrade | Equal-Weight → Overweight | |||
01/06/2023 | -26.4% | Exane BNP Paribas | → $64.5 | Initiates | → Neutral | |||
01/04/2023 | -11% | Morgan Stanley | $80 → $78 | Upgrade | Equal-Weight → Overweight |
FAQ
Quel est le cours indicatif de l'action TransUnion (TRU) ?
Le dernier objectif de prix pour TransUnion (NYSE:TRU) a été rapporté par UBS le juillet 25, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $105.00 s'attendant à ce que TRU se rise dans les 12 prochains mois (un possible changement de 19.81% upside). 34 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour TransUnion (TRU) ?
La dernière note d'analyste pour TransUnion (NYSE:TRU) a été fournie par UBS, et TransUnion maintenu leur note neutral.
Quand a eu lieu la dernière mise à niveau pour TransUnion (TRU) ?
La dernière amélioration pour TransUnion a eu lieu le octobre 10, 2024 lorsque Wolfe Research a augmenté leur objectif de prix à $130. Wolfe Research avait précédemment a peer perform pour TransUnion.
Quand a eu lieu la dernière dégradation pour TransUnion (TRU) ?
La dernière réduction pour TransUnion a eu lieu le octobre 25, 2023 lorsque Evercore ISI Group a changé leur objectif de prix de N/A à N/A pour TransUnion.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour TransUnion (TRU) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de TransUnion, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour TransUnion a été déposée le juillet 25, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers juillet 25, 2026.
La note d'analyste pour TransUnion (TRU) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de TransUnion (TRU) était un maintenu avec un objectif de prix de $98.00 à $105.00. Le prix actuel de TransUnion (TRU) est de $87.64, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.